Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
MRD-guided therapy debate
Prof Ola Landgren - University of Miami, Miami, USA
18 Sep 2021
KEYNOTE-716: Adjuvant pembrolizumab prolongs recurrence-free survival in resecte...
Dr Jason Luke - UPMC Hillman Cancer Center, Pittsburgh, USA
18 Sep 2021
Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical ...
Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA
18 Sep 2021
Cabozantinib in combination with atezolizumab in patients with mCRPC
Prof Neeraj Agarwal - University of Utah School of Medicine, Salt Lake CIty, US...
18 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 2
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
18 Sep 2021
Long-term outcomes and complications in cancer patients who have recovered from ...
Dr David Pinato - Imperial College London, London, UK
17 Sep 2021
6 months trastuzumab non-inferior to 12 months for HER2 positive early breast ca...
Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom
17 Sep 2021
Erdafitinib (ERDA) or ERDA plus cetrelimab for patients with metastatic or local...
Prof Thomas Powles - Queen Mary University of London, London, UK
17 Sep 2021
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
17 Sep 2021
Nivolumab plus ipilimumab shows benefit over chemo for unresectable malignant pl...
Prof Solange Peters - Lausanne University Hospital, Lausanne, Switzerland
17 Sep 2021
OncoAlert and ecancer - ESMO 2021 preview
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Sep 2021
Safety and efficacy of isatuximab plus bortezomib, lenalidomide, and dexamethaso...
Dr Enrique Ocio - Marqués de Valdecilla University Hospital, Santander, Spain
14 Sep 2021
